Sackler Family’s OxyContin Firm To Face Suit From Native Americans
The prescription opioid painkiller OxyContin is displayed at a drugstore. Image by Getty Images
By Josh Nathan-Kazis January 10, 2018
The OxyContin manufacturer Purdue Pharma, along with two dozen other opioid makers, are facing a lawsuit brought by three Native American tribes in the Dakotas, claiming that the firms hid the drug’s risk.
Purdue is privately owned by the Sackler family, who are Jewish. (After the publication of this brief, a representative for one branch of the family, the descendants of Arthur M. Sackler, contacted the Forward to note that their branch sold their share of the firm in the 1980s and has never benefited from the sale of OxyContin.)
According to the Associated Press, the three tribes are asking for monetary damages and a fund to pay for addiction treatment.
“This epidemic has overwhelmed our public-health and law-enforcement services, drained resources for addiction therapy, and sent the cost of caring for children of opioid-addicted parents skyrocketing,” Brendan Johnson, a lawyer representing the tribes, told the AP.
Native American populations in South Dakota have been disproportionately affected by the opioid crisis.
Contact Josh Nathan-Kazis at [email protected] or on Twitter, @joshnathankazis.
Hello, fellow Forward reader! I’m Joel Brown, a Forward reader and supporter for more than 15 years, and currently the chair of the board of directors.
I’m an avid Forward reader because it ticks so many of my essential boxes: excellent journalism, Jewish focus and diverse viewpoints. In today’s political climate, what I most appreciate is the Forward’s independence — made possible by the generosity of its membership.
The Forward is committed to bringing you unbiased, nuanced Jewish news. From my position as board chair, I see an exciting future as we expand our position as the definitive independent voice of contemporary American Judaism.
That’s why I’m paying it Forward, by matching $36,000 of reader gifts. It’s an investment in the Forward’s newsroom, to continue telling the American Jewish story with truth and independence.
— Joel Brown, Forward board chair
Support our mission to tell the Jewish story fully and fairly.
